Grants
Our Polish subsidiary is performing research and development under the Operational Programme – Smart Growth 2014-2020. Specific funded projects are high-lighted below.
Project title: Development of a new candidate microbicide for the prevention of HIV transmission
The aim of the Project is to develop an innovative microbicide drug candidate that is used in the prevention of sexually transmitted infections (STIs) – in particular in the prevention of HIV – a lifestyle disease.
Application for project co-funding within European Union, European Regional Development Fund:
- Total project amount: 9,928,239.50 PLN
- Co-funding portion: 7,034,900.75 PLN
Project title: CCR5 Immunotherapy for Advanced Cancer
The project will develop a product innovation – the first in its class (first-in-class) drug candidate for use in the treatment of colorectal cancer. The target is to develop an effective drug, which will help with inhibition of tumor growth and stopping the metastatic colorectal cancer (CRC).
Application for project co-funding within European Union, European Regional Development Fund:
- Total project amount: 9,822,015.00 PLN
- Co-funding portion: 6,873,131.75 PLN
Global Headquarters
343 Preston Street
11th floor,
Ottawa, On K1S 1N4
CANADA
+1 343.291.1032
Switzerland
Campus Biotech
Innovation Park
Avenue de Sécheron 15
1202 Genève
SWITZERLAND
Poland
Orion Biotechnology
Life Science Park
UI Bobrzyńskiego 14
30-348 Krakôw
POLAND
